DESLORATADINE TABLETS

Krajina: Kanada

Jazyk: angličtina

Zdroj: Health Canada

Kúpte ho teraz

Aktívna zložka:

DESLORATADINE

Dostupné z:

APOTEX INC

ATC kód:

R06AX27

INN (Medzinárodný Name):

DESLORATADINE

Dávkovanie:

5MG

Forma lieku:

TABLET

Zloženie:

DESLORATADINE 5MG

Spôsob podávania:

ORAL

Počet v balení:

10/12/20/24/30/36/48/50

Typ predpisu:

OTC

Terapeutické oblasti:

SECOND GENERATION ANTIHISTAMINES

Prehľad produktov:

Active ingredient group (AIG) number: 0143961001; AHFS:

Stav Autorizácia:

APPROVED

Dátum Autorizácia:

2010-02-05

Súhrn charakteristických

                                Page 1 of 35
PRODUCT MONOGRAPH
DESLORATADINE TABLETS 5 MG DESLORATADINE
HISTAMINE H
1
-RECEPTOR ANTAGONIST
APOTEX INC.
DATE OF REVISION:
150 SIGNET DRIVE
OCTOBER 17, 2018
TORONTO, ONTARIO
M9L 1T9
CONTROL NUMBER: 220366
Page 2 of 35
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
........................................................ 3
SUMMARY
PRODUCT
INFORMATION
................................................................................
3
INDICATIONS
AND
CLINICAL
USE
......................................................................................
3
CONTRAINDICATIONS
...........................................................................................................
3
WARNINGS
AND
PRECAUTIONS
..........................................................................................
3
ADVERSE
REACTIONS
...........................................................................................................
5
DRUG
INTERACTIONS
............................................................................................................
6
DOSAGE
AND
ADMINISTRATION
........................................................................................
7
OVERDOSAGE
..........................................................................................................................
7
ACTION
AND
CLINICAL
PHARMACOLOGY
.......................................................................
7
STORAGE
AND
STABILITY
..................................................................................................
10
SPECIAL
HANDLING
INSTRUCTIONS
...............................................................................
10
DOSAGE
FORMS,
COMPOSITION
AND
PACKAGING ...................................................... 10
PART II: SCIENTIFIC INFORMATION
...............................................................................
12
PHARMACEUTICAL
INFORMATION
.................................................................................
12
CLINICAL
TRIALS
.............................
                                
                                Prečítajte si celý dokument
                                
                            

Dokumenty v iných jazykoch

Súhrn charakteristických Súhrn charakteristických francúzština 17-10-2018

Vyhľadávajte upozornenia súvisiace s týmto produktom

Zobraziť históriu dokumentov